Mortality News and Research

RSS

Daxor's BVA-100 diagnostic blood test reduces hospital length of stay for heart failure patients

Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company's BVA-100 diagnostic blood test in reducing hospital length of stay (LOS) for heart failure (HF) patients.

3 Oct 2022

New data validates the benefits of Daxor's BVA-100 blood test for heart failure patients

Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company's BVA-100 blood test for heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world's leading experts in heart failure from September 30th thru October 3rd, 2022, in Washington, DC.

3 Oct 2022

Black women more likely to die from breast cancer despite lower incidence, ACS report finds

While breast cancer death rates dropped by 43% from 1989 to 2020, Black women continue to be 40% more likely to die from the disease despite lower incidence.

3 Oct 2022

Is it safe to breastfeed after the COVID-19 mRNA vaccination?

A recent study attempts to answer the question of whether the COVID-19 vaccine is safe for lactating women who received the vaccine within six months postpartum.

3 Oct 2022

French study reports growing evidence of sexual activity-linked transmission of monkeypox

In a new study, researchers described patients with monkeypox virus (MPXV) infection.

3 Oct 2022

Novel linear DNA SARS-CoV-2 vaccine using electroporation-aided vaccine delivery reveals lower viral shedding in ferrets

Researchers evaluated the efficacy, immunogenicity, and safety of a novel SARS-CoV-2 linear deoxyribonucleic acid vaccine in ferret models delivered using intramuscular injection and electroporation.

3 Oct 2022

Vaccine effectiveness of a second mRNA COVID-19 vaccine booster among nursing home residents

Researchers compared the effectiveness of double booster SARS-CoV-2 mRNA vaccinations and single booster vaccinations among nursing home residents in the US.

3 Oct 2022

Improving care and reducing the morbidity, mortality associated with pediatric AKI

Acute kidney injury occurs (AKI) in one out of four babies, children and young adults during an intensive care stay for any reason, and yet the condition is poorly understood.

30 Sep 2022

Clinical features and outcomes of fulminant myocarditis revealed by nationwide cohort study

Myocarditis is an inflammatory disease of the myocardium often caused by viral infections or autoimmune disorders. Fulminant myocarditis (FM) is a rare and severe presentation of myocarditis characterized by hemodynamically unstable conditions requiring inotropes and/or mechanical circulatory support.

30 Sep 2022

Patients with scleroderma have reduced levels of Cathepsin L

Much of the research on scleroderma, a connective tissue disease that causes scarring, or fibrosis, has focused on the increased number of proteins promoting fibrosis in these patients. A Medical University of South Carolina (MUSC) research team took a different tact and measured the levels of an antifibrotic protein, Cathepsin L, in these patients.

30 Sep 2022

Primary vaccinations and boosters effective in reducing COVID-19 severity during Delta and Omicron predominance

In a new study, researchers analyzed COVID-19 vaccination and surveillance data to understand the effect of primary vaccinations, boosters, and prior SARS-CoV-2 infections on severe COVID-19 outcomes and subsequent infections.

29 Sep 2022

What are the associations between coffee intake and cardiovascular disease?

In new research, researchers evaluated the impact of coffee consumption on the incidence of cardiovascular disease (CVD), arrhythmias, and mortality.

29 Sep 2022

What is the relationship between weightlifting and all-cause mortality?

A recent study investigated the relationship between weightlifting and all-cause mortality, especially death due to cardiovascular disease and cancer.

29 Sep 2022

TGen and ASU partner with Phoenix Children’s and Cincinnati Children’s to better understand NAFLD

The prevalence of nonalcoholic Fatty Liver Disease, NAFLD, is rising in American children, with kids of Latino ancestry being hit disproportionately hard by the disease.

28 Sep 2022

ED-ICU model can provide higher value care without increasing costs

Across the country, many intensive care units are strained for capacity. This prolongs the boarding process in the emergency department, when critically ill patients – for whom every minute and hour is crucial – wait for open ICU beds.

28 Sep 2022

Houston Methodist researchers receive CPRIT funding to research two of the most lethal cancers

Two Houston Methodist cancer researchers have been awarded a half million dollars in funding from the Cancer Prevention and Research Institute of Texas to further research two of the most lethal, difficult-to-treat cancers that all-too-often have poor prognoses.

28 Sep 2022

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19

Researchers evaluated the efficacy of the anti-inflammatory drug dimethyl fumarate in treating COVID-19 as part of an early phase, randomized, controlled assessment trial in the UK.

28 Sep 2022

Wastewater epidemiology can guide local clinical decisions on circulating viruses

The findings of a new study posted to the medRxiv* preprint server depicted that wastewater-based epidemiology (WBE) can provide information on the circulating respiratory viruses in a community. As well as saving time and money, this method may assist in appropriate clinical decision-making, behavior modification, and public health interventions.

28 Sep 2022

How the gut microbiome could affect COVID-19 severity

Researchers review the potential role of the gut microbiome in determining severe COVID-19.

27 Sep 2022

Emergency dialysis during hospitalization for surgery predicts unfavorable outcomes

Even the best-laid plans often go awry, and adapting to changing circumstances on the fly can lead to unanticipated results.

27 Sep 2022

Mortality News and Research

Daxor's BVA-100 diagnostic blood test reduces hospital length of stay for heart failure patients

New data validates the benefits of Daxor's BVA-100 blood test for heart failure patients

Black women more likely to die from breast cancer despite lower incidence, ACS report finds

Is it safe to breastfeed after the COVID-19 mRNA vaccination?

French study reports growing evidence of sexual activity-linked transmission of monkeypox

Novel linear DNA SARS-CoV-2 vaccine using electroporation-aided vaccine delivery reveals lower viral shedding in ferrets

Vaccine effectiveness of a second mRNA COVID-19 vaccine booster among nursing home residents

Improving care and reducing the morbidity, mortality associated with pediatric AKI

Clinical features and outcomes of fulminant myocarditis revealed by nationwide cohort study

Patients with scleroderma have reduced levels of Cathepsin L

Primary vaccinations and boosters effective in reducing COVID-19 severity during Delta and Omicron predominance

What are the associations between coffee intake and cardiovascular disease?

What is the relationship between weightlifting and all-cause mortality?

TGen and ASU partner with Phoenix Children’s and Cincinnati Children’s to better understand NAFLD

ED-ICU model can provide higher value care without increasing costs

Houston Methodist researchers receive CPRIT funding to research two of the most lethal cancers

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19

Wastewater epidemiology can guide local clinical decisions on circulating viruses

How the gut microbiome could affect COVID-19 severity

Emergency dialysis during hospitalization for surgery predicts unfavorable outcomes

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News